0001564590-21-006942 | 10-K | XBRL Viewer

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2020	Feb. 17, 2021	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Trading Symbol	TLRY
Entity Registrant Name	TILRAY, INC.
Entity Central Index Key	0001731348
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		171,757,688
Entity Public Float			$ 675.6
Title of 12(b) Security	Class 2 Common Stock, $0.0001 par value per share
Entity File Number	001-38594
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-4310622
Entity Interactive Data Current	Yes
Security Exchange Name	NASDAQ
Entity Address, Address Line One	1100 Maughan Road
Entity Address, City or Town	Nanaimo
Entity Address, State or Province	BC
Entity Address, Postal Zip Code	V9X IJ2
City Area Code	844
Local Phone Number	845-7291
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference from the definitive proxy statement to be filed by the registrant in connection with the 2021 Annual Meeting of Stockholders (the “Proxy Statement”) with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the year ended December 31, 2020, provided that if such Proxy Statement is not filed within such period, such information will be included in an amendment to this Form 10‑K to be filed within such 120-day period.

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 189,702	$ 96,791
Accounts receivable, net of allowance for credit losses of $887 and provision for sales returns of $1,651 (December 31, 2019 - $615 and $1,400, respectively)	29,033	36,202
Inventory	93,645	87,861
Prepayments and other current assets	34,640	38,173
Total current assets	347,020	259,027
Property and equipment, net	199,559	184,217
Operating lease, right-of-use assets	17,985	17,514
Intangible assets, net	186,445	228,828
Goodwill	166,915	163,251
Equity method investments	9,300	11,448
Other investments	14,369	24,184
Other assets	4,356	7,861
Total assets	945,949	896,330
Current liabilities
Accounts payable	17,776	39,125
Accrued expenses and other current liabilities	39,946	50,829
Accrued lease obligations	2,913	2,473
Warrant liability	120,647
Total current liabilities	181,282	92,427
Accrued lease obligations	30,623	29,407
Deferred tax liability	49,274	53,363
Convertible notes, net of issuance costs	257,789	430,210
Senior Facility, net of transaction costs	48,470
Other liabilities	4,612	5,652
Total liabilities	572,050	611,059
Commitments and contingencies (refer to Note 20)
Stockholders’ equity
Additional paid-in capital	1,095,781	705,671
Accumulated other comprehensive income	8,205	9,719
Accumulated deficit	(730,103)	(430,130)
Total stockholders' equity	373,899	285,271
Total liabilities and stockholders' equity	945,949	896,330
Class 1 common stock [Member]
Stockholders’ equity
Common stock value		2
Class 2 common stock [Member]
Stockholders’ equity
Common stock value	$ 16	$ 9

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Allowance for doubtful accounts receivable	$ 887	$ 615
Provision for sales returns	$ 1,651	$ 1,400
Class 1 common stock [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	233,333,333	250,000,000
Common stock, shares issued	0	16,666,667
Common stock, shares outstanding	0	16,666,667
Class 2 common stock [Member]
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	158,456,087	86,114,558
Common stock, shares outstanding	158,456,087	86,114,558

Consolidated Statements of Net Loss and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Income Statement [Abstract]
Revenue	$ 210,482	$ 166,979	$ 43,130
Cost of sales	185,827	190,475	28,855
Gross profit (loss)	24,655	(23,496)	14,275
General and administrative expenses	85,883	110,903	48,577
Sales and marketing expenses	54,666	63,813	15,828
Research and development expenses	4,411	9,172	5,864
Depreciation and amortization expenses	13,722	11,607	1,598
Impairment of assets	61,114	112,070
Acquisition-related (income) expenses, net		(31,427)	248
Loss from equity method investments	5,983	4,504
Operating loss	(201,124)	(304,138)	(57,840)
Foreign exchange (gain) loss, net	(13,169)	(5,944)	7,234
Change in fair value of warrant liability	100,286
Gain on debt conversion	(61,118)
Interest expenses, net	39,219	34,690	9,110
Finance income from ABG		(764)
Other expenses (income), net	10,333	(2,501)	(2,010)
Loss before income taxes	(276,675)	(329,619)	(72,174)
Deferred income tax recoveries	(5,376)	(8,847)	(4,485)
Current income tax (recoveries) expenses	(226)	397	34
Net loss	$ (271,073)	$ (321,169)	$ (67,723)
Net loss per share - basic and diluted	$ (2.15)	$ (3.20)	$ (0.82)
Weighted average shares used in computation of net loss per share - basic and diluted	126,041,710	100,455,677	83,009,656
Net loss	$ (271,073)	$ (321,169)	$ (67,723)
Foreign currency translation (loss) gain, net	(1,497)	5,174	662
Unrealized loss on investments	(17)	(21)	(765)
Other comprehensive income (loss)	(1,514)	5,153	(103)
Comprehensive loss	$ (272,587)	$ (316,016)	$ (67,826)

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands

Total

At-the-Market [Member]

Cumulative Effect, Period of Adoption, Adjustment [Member]

Alef [Member]

Natura Naturals Inc

Natura Contingent Consideration

Manitoba Harvest U S L L C

Investments

S And S Acquisition

ABG [Member]

Preferred Shares [Member]

Common Stock [Member]

At-the-Market [Member]

Common Stock [Member]

Alef [Member]

Common Stock [Member]

Natura Naturals Inc

Common Stock [Member]

Natura Contingent Consideration

Common Stock [Member]

Manitoba Harvest U S L L C

Common Stock [Member]

Investments

Common Stock [Member]

S And S Acquisition

Common Stock [Member]

Downstream Merger [Member]

Common Stock [Member]

ABG [Member]